PFE Stock Analysis: Buy, Sell, or Hold?
PFE - Pfizer Inc.
$27.30
0.26 (0.94%)
▲
5d:
+1.96%
30d:
-1.28%
90d:
+8.79%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 05, 2026
Smart Money Accumulation
PFE is down 3.4% this week, but smart money is accumulating calls. Top strike: $27 2026-04-17 with 31,313 OI. Call ratio: 62% View Scanner →
Strength: 2.9/10
Get Alerted When PFE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PFE shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: PFE shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$24.97
Based on -0.3% avg growth
INTRINSIC VALUE TODAY
$15.50
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PFE is currently trading at $27.30, which is considered fair relative to its 30-day fair value range of $26.74 to $27.36. The stock's valuation (Forward PE: 9.6) is in line with its historical norms (9.0). At these levels, the market is pricing in 2.3% annual earnings growth.
Technical Outlook: Technically, PFE is in a strong uptrend. The price is approaching resistance at $27.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PFE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PFE is in a strong uptrend. The price is approaching resistance at $27.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PFE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$26.74 -
$27.36
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
81.9%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($28.58)
- BULLISH: Expecting earnings turnaround to 2.3% growth with -1.2% revenue growth
Fair Price Analysis
30-Day Fair Range
$26.74 -
$27.36
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$26.44
Resistance Level
$27.81
Current Trend
Strong Uptrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.58
Wall Street Target
$28.58
(+5.7%)
Revenue Growth (YoY)
-1.2%
Earnings Growth (YoY)
-21.3%
Profit Margin
12.4%
Valuation Premium vs History
+2.3% premium
PE vs Historical
9.6 vs 9.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.3%
(market-implied from PE analysis)
1-Year Target
$27.66
(+2%)
2-Year Target
$28.30
(+5%)
3-Year Target
$28.95
(+7%)
3-Yr Target (if PE normalizes)
(PE: 10→9)
PE COMPRESSION
$27.20
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: -4.6%)
$54.84
(+103%)
Base:
(SPY PE: 9.6, Growth: -4.6%)
$23.45
(-13%)
Bear:
(PE: 8.1, Growth: -4.6%)
$19.93
(-26%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 19.83 | Current EPS (TTM): $1.36
Bull Case
$59.33
(+122%)
Analyst growth 100.0%, PE expands to 21.8
Base Case
$53.94
(+102%)
Market implied 100.0%, PE stable at 19.8
Bear Case
$18.34
(-32%)
Severe decline -20.0%, PE contracts to 16.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: March 30, 2026 10:13 AM ET
Data refreshes hourly during market hours. Next update: 11:13 AM
Data refreshes hourly during market hours. Next update: 11:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PFE showing a specific setup today?
Insider Activity (6 Months)
2
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Gilbert Ray Cisneros, Jr.
BUY
2026-02-10
Ro Khanna
SELL
2026-01-22
J. French Hill
SELL
2025-12-31
Featured in Portfolios
PFE is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1209 | 51 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$157 | 57 HOLD |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$206 | 62 BUY |
|
MRK
Merck & Company Inc |
BUY
26 analysts |
$128 | 68 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$351 | 58 HOLD |
Advanced PFE Option Strategies
Professional options setups generated by AI based on today's PFE price and gamma walls.
